Linde India Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹723 Cr +12.3% YoYSee revenue, profit and what management said. You are viewing Q1 FY25.
L

Linde India Ltd

Q1 FY25Chemicals & Petrochemicals

Linde India Q1 FY25 earnings call: Revenue & Margins

Q1 FY25 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹653Cr
+3.7% QoQ
Net profit
₹112Cr
+7.7% QoQ
Margin
28%
0 pp QoQ

Linde India Ltd Q1 FY25 key numbers

Revenue
Revenue for year ended Mar 2024: ₹27,687 million, down 12% vs. 15-month ended Mar 2023 (₹31,355 million).

As stated in Linde India Ltd's Q1 FY25 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.

Based on Linde India Ltd's Q1 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹6,196
Market cap₹53.2K Cr
P/E97.0

The short version

Revenue for year ended Mar 2024: ₹27,687 million, down 12% vs. 15-month ended Mar 2023 (₹31,355 million). EBITDA: For year ended March 2024, EBITDA was INR 7,793 million, down 11% from INR 8,736 million for the 15-month period ended March 2023 (Page 9 and 8).

From Linde India Ltd's Q1 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Revenue for year ended Mar 2024: ₹27,687 million, down 12% vs. 15-month ended Mar 2023 (₹31,355 million).
  • When compared on a similar 12-month basis, revenue grew 6.4% YoY.
  • Gases division revenue grew 10.2% YoY (+₹1,840 million), driven by high gas & liquid demand and pricing discipline.
  • Project Engineering Division (PED) revenue declined marginally by 2.2% YoY (-₹166 million) due to project billing cycles.
  • EBITDA declined 11% YoY but showed a 7.2% increase when compared on a similar 12-month basis.

2 more points from Linde India Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Linde India Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Healthy Order book of ~20 billion INR as of March 2024 (Page 5).
  • Focus on expanding manufacturing and project capabilities in high-growth markets and segments such as metallurgy (steel, stainless steel), chemistry (pharma, chemicals), food & beverage (N2 dosing, cryo-grinding), healthcare (PSA, MGPS), electronics (semiconductors, PV solar), and primary metals (steel, copper, aluminium) (Page 12).
  • Ongoing digitalization projects including Production Planning tools (iPlan, MPC+), Engineering Design Assist (PED), and eRFQ for vendor selection, some marked as "Work in Progress" (Page 14).

2 more points from Linde India Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Linde India Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The presentation reports a healthy order book position of approximately ₹20 billion as of March 2024 (Page 5).
  • It highlights the Project Engineering Division (PED) having a strong and resilient focus to win projects across diverse industries despite a marginal revenue decline (Page 5).

Linde India Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Linde India Ltd Q1 FY25 results — key figures

Linde India Ltd Q1 FY25 reported results vs year-ago quarter, ₹ crore
₹ CrQ1 FY25Q4 FY24QoQ
Revenue653630+3.7%
Operating profit (EBITDA)184179+2.8%
Operating margin28%28%0 pp
Profit before tax150141+6.4%
Net profit (PAT)112104+7.7%
EPS (₹)13.0812.23+7%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹723 Cr, net profit ₹115 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Himadri Special (Q1 FY25)

    1,199.77 Cr, up 26.17% YoY (vs Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.

  • Balaji Amines (Q1 FY25)

    Q1FY25 consolidated revenue from operations: ₹393 crore, down 16% YoY from ₹469 crore in Q1FY24 (Page 5 & 6). Key concall takeaways from Balaji Amines Ltd's Q1…

  • Vidhi Specialty (Q1 FY25)

    83.0 Crs, up 4.1% year-on-year from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY25 earnings call — and how it ranks against…

  • GOCL Corporation (Q1 FY25)

    Consolidated revenue for FY 2023-24: INR 949 crores, down from INR 1409.71 crores in FY 2022-23. Key concall takeaways from GOCL Corporation Ltd's Q1 FY25…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Linde India Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Linde India Ltd Q1 FY25 results?

Revenue for year ended Mar 2024: ₹27,687 million, down 12% vs. 15-month ended Mar 2023 (₹31,355 million). EBITDA: For year ended March 2024, EBITDA was INR 7,793 million, down 11% from INR 8,736 million for the 15-month period ended March 2023 (Page 9 and 8).

What is Linde India Ltd share price analysis?

Linde India Ltd currently shows a neutral. The stock trades at a P/E of 97.0 with a market cap of ₹53,228 Cr. Investors should review the full earnings analysis for detailed insights.

Is Linde India Ltd planning capital expenditure?

Healthy Order book of ~20 billion INR as of March 2024 (Page 5).

Keep Linde India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.